Kedrion Biopharma India Private Limited, a under liquidation foreign private limited company, was established on 06 December 2013 in New Delhi, Delhi, India. Engaging in pharmaceutical retailers & distributors within the trade sector, it holds CIN: U52100DL2013FTC261763. Registered under ROC Roc Delhi. it is unlisted. It has an authorized capital of ₹1.39 Cr and a paid-up capital of ₹1.29 Cr.
It upholds a compliant status. Its leadership includes Ferdinando Borgese (Managing Director), Vijay Khurana (Director), Avninder Singh (Director). Past directors included Sanjiv Khurana, Rahul Tewari, Andrea Benassi. Its latest AGM occurred on 18 October 2021, with the balance sheet filed on 31 March 2021. It is based at House No. R-265C, Ground Floor Greater Kailash Part-I, New Delhi, Delhi, 110048.
U52100DL2013FTC261763
261763
06 December 2013
₹1.39 Cr
₹1.29 Cr
Roc Delhi
Unlisted
Under Liquidation
Explore comprehensive insights into Kedrion Biopharma India Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Ferdinando Borgese | Managing Director | 07 Jul 2017 | Current |
| Vijay Khurana | Director | 16 Oct 2020 | Current |
| Avninder Singh | Director | 06 Dec 2013 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 05 Sep 2018 | Past |
| Pramod Abcsdd | Director | 30 Nov 2019 | Past |
| Pramod Abcsdd | Managing Director | 16 Jun 2017 | Past |
| Pramod Abcsdd | Director | 08 Jul 2017 | Past |
| Pramod Abcsdd | Additional Director | 25 Nov 2020 | Past |
| Pramod Abcsdd | Managing Director | 16 Feb 2016 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Kedrion Biopharma India Private Limited, for the financial year ended 2020, experienced significant growth in revenue, with a 17.9% increase. The company also saw a substantial fall in profitability, with a 143.53% decrease in profit. The company's net worth observed a substantial decline by a decrease of 33.65%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2020, Kedrion Biopharma India had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
There are no open charges registered against the company as per our records.
Unlock and access historical data on people associated with Kedrion Biopharma India, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Kedrion Biopharma India, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Kedrion Biopharma India's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
The activity Kedrion Biopharma India Private Limited last Annual general meeting of members was held on 18 Oct 2021 as per latest MCA records. was completed.
The activity Kedrion Biopharma India Private Limited has filed its annual Financial statements for the year ended 31 Mar 2021 with Roc Delhi. was completed.
Progress on Vijay Khurana was appointed as a Director was appointed as a Director on 16 Oct 2020 & has been associated with this company since 5 years 1 month . was documented.
The activity Ferdinando Borgese was appointed as a Managing Director was appointed as a Managing Director on 07 Jul 2017 & has been associated with this company since 8 years 4 months . was completed.
Progress on Avninder Singh was appointed as a Director was appointed as a Director on 06 Dec 2013 & has been associated with this company since 11 years 11 months . was documented.
Progress on Kedrion Biopharma India Private Limited was registered on 06 Dec 2013 with Roc Delhi & aged 11 years 11 months as per MCA records. was documented.
The CIN of Kedrion Biopharma India Private Limited is U52100DL2013FTC261763.
Kedrion Biopharma India Private Limited is headquartered at House No. R-265C, Ground Floor Greater Kailash Part-I, New Delhi, Delhi, 110048.
Kedrion Biopharma India Private Limited was incorporated on 06 December 2013.
The current directors of Kedrion Biopharma India Private Limited are
The primary industry of Kedrion Biopharma India Private Limited is Trade.
Kedrion Biopharma India Private Limited is unlisted.
The authorized capital of Kedrion Biopharma India Private Limited is ₹1.39 Cr, and the paid-up capital is ₹1.29 Cr.
The compliance status of Kedrion Biopharma India Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX